| Gene symbol | GUCY2C | Synonyms | DIAR6, GC-C, GCC, GUC2C, HSER, MECIL, MUCIL, STAR | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p12.3 | dbXrefs | |
| Description | guanylate cyclase 2C | ||||
| GTO ID | GTC2967 |
| Trial ID | NCT05287165 |
| Disease | Colorectal Cancer | Advanced Solid Tumor | Pancreatic Cancer | Digestive System Neoplasm |
| Altered gene | GUCY2C |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IM96 |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms |
| Year | 2022 |
| Country | China |
| Company sponsor | Beijing Immunochina Medical Science & Technology Co., Ltd. |
| Other ID(s) | YMCART9601 |
| Cohort 1 | |||||||||
|
|||||||||